MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading ->
World Health Organization (WHO) member states have agreed that the future pandemic “treaty” currently being negotiated will be legally binding at the Intergovernmental Negotiating Body (INB) meeting that ended on Thursday – a day earlier than expected thanks to smooth negotiations. The INB agreed that the treaty will be set up in terms of Article […] Continue reading ->
COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading ->
Major pharmaceutical companies have offered to reserve a “real-time allocation” of vaccines and treatments upfront for “priority populations in lower-income countries” in future pandemics – providing the G7 and G20 also help low-income countries finance and make effective use of the products. Launching its Berlin Declaration on Tuesday, the International Federation of Pharmaceutical Manufacturers and […] Continue reading ->
Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading ->